Tamoxifen vs Aromatase Inhibitors and highlights of San Antonio Breast Cancer Symposium

Bookmark and Share
Published: 9 Jan 2009
Views: 17626
Professor Mitch Dowsett, Professor of Biochemical Endocrinology at the Institute of Cancer Research
Highlights of the San Antonio Breast Cancer Symposium, Aromatase Inhibtors vs Tamoxifen, Survival Benefit, BIG 1-98, Letrozole